(2-Imidazol-1-yl-ethyl)-methyl-amine, 95.0%, 250mg

(4S,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride, 98.0%, 100g

N-([1,1'-Biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine, 97%, 25g

(1H-Indazol-4-yl)methanamine dihydrochloride, 95.0%, 100mg

3-(3-(Trifluoromethyl)phenyl)propanenitrile, 97%, 5g

4-(2,3,4,5,6-Pentamethylphenyl)-4-oxobutyric acid, 97.0%, 1g

(2s,4r)-4-Fluoropyrrolidine-2-carboxamide hydrochloride, 95+%, 1g

(1R,2S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclohexanecarboxylic acid, 95.0%, 250mg

Single-channel microliter pipette set Acura® manual XS 826 TwiXS Pack, TwiXS G, 0.5-10 / 10-100 µl, 1 Set

2-Chloro-5-ethoxypyrimidine, 95.0%, 250mg

2,3-Difluoroiodobenzene, 97.0%, 10g

4-n-Octyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene>96.0%(GC)1g

ETHYL 5-BENZOXAZOLECARBOXYLATE, 97.0%, 1g